Following September-quarter earnings, HDFC Sec has maintained its postive stance on 15 stocks across ports, including LIC, Apollo Hospitals, Titan Company, Aurobinod Pharma, Ipca Labs, and more.
Following September-quarter earnings, HDFC Sec has maintained its postive stance on 15 stocks across ports, including LIC, Apollo Hospitals, Titan Company, Aurobinod Pharma, Ipca Labs, and more.
<iframe src="https://hindustansphere.com/embed/cluster/98868ae8245c2373a10fa84c1c4c5ddd4712e6fd" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="LIC, Apollo Hospitals Among 15 Stocks In HDFC Securities' Q2 Review, Upside Up To 73%; Check Target Prices"></iframe>
